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in mind that elective EVAR is a prophylactic operation for an
asymptomatic condition. From a public health standpoint, it is
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As the population continues to age, vascular surgeons will
continue to be confronted with the difficult problem of treating
increasingly elderly patients. In this article, the authors address the
issue of endovascular abdominal aortic aneurysm repair (EVAR) in
nonagenarians, a population of patients clearly expected to increase
in the coming decades. The data from their report can be used to
both support and refute the wisdom of performing EVAR in
patients in their ninth decade.
Although procedural results were “acceptable,” to use the
authors’ word, perioperative morbidity (25%) and mortality (8.3%)
were much higher than what we have come to expect from EVAR
in the general population. Ultimately,20% of the patients died as
a direct result of the aneurysm or the repair, so it is not clear that
EVAR in this patient group has improved the natural history of the
disease. Furthermore, one has to question the wisdom of extend-
ing expensive health care resources to patients with limited life
expectancy, only 19% at 5 years in this study. It must always be keptuestionable whether the cost/benefit ratio pencils out in this
cenario.
On the other hand, all vascular surgeons have seen and treated
he “vigorous” nonagenarian whose health and quality of life defy
heir chronologic age. Although, as one of my mentors once told
e, they may not look 90 before their operation, they always look
0 afterward. Clearly, though, there exists a subset of nonagenar-
ans for whom EVAR is appropriate. Unfortunately, the numbers
reated in this study were not large enough to stratify patients to
etermine factors predicting good and poor outcomes. Given the
arity of this procedure in nonagenarians, it is unlikely that a single
enter would be able to do so, and pooled data from multiple
enters may be necessary to answer this question and identify
onagenarians for whom this procedure is most appropriate.
The authors are to be congratulated for critically analyzing
nd presenting their results in this difficult group of patients. The
onclusions are open to debate, and this article does not provide a
efinitive answer; however, it does serve as a point of comparison
or future studies that address this issue.
